Close Menu

NEW YORK (GenomeWeb) – A draft document published today by the UK's National Institute for Health and Care Excellence (NICE) reverses a previous endorsement for the use of Genomic Health's Oncotype Dx test in guiding chemotherapy decisions for breast cancer patients.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Jul
23

This webinar will discuss how the Molecular Pathology Laboratory at the University of Oklahoma (OUMP) is using a new quality improvement model to support molecular testing of oncology patients.